Due to the ORA-wide office relocation, the HRPP offices will be closed on Friday, August 28th.
Effective Monday, August 31st, the HRPP will be located at 25 Science Park - 3rdFloor, 150 Munson St.
Please note that we may not have the ability to access email until late in the day on Monday, August 31st. Therefore, please plan your work accordingly and submit any urgent requests before noon on Wednesday, August 26th.
We thank you for your patience during this process!
New Mailing Address: P.O. Box 208327
New Haven CT 06520-8327
Please make a note of this address change and update your records accordingly.
All telephone numbers will remain the same.
Yale University has established a new FDA approved Radioactive Drug Research Committee (RDRC) with Dr. Albert Sinusas as the committee Chair. Yale New Haven Hospital (YNHH) will be closing out the YNHH RDRC, and transferring all protocols to the Yale RDRC. Faculty researchers conducting research at the University that requires RDRC approval should no longer submit these applications to the Yale New Haven Hospital RDRC as this committee is not receiving or reviewing research protocols going forward. The Yale RDRC will continue to work in conjunction with the Yale University Radiation Safety Committee (RSC).
On behalf of the Yale University academic community we would like to acknowledge Dr. Ravinder Nath and the YNHH RDRC committee members for their tremendous efforts in operation of the RDRC on behalf of Yale University investigators for many years.
The information and instructions on this website will be modified and updated with operation of the new Yale RDRC, so please check this website prior to any submissions for changes in policy and forms.
For questions regarding the application process, approvals and/or future committee meeting dates and deadlines, please contact Donna McMahon at RDRC_admin@yale.edu.
The Yale University Institutional Review Board (HIC/HSC) periodically
revises forms that are required for submission (e.g., new application,
renewal form, amendment form, etc.). Changes to the forms generally are
based on information that is required to provide the reviewer with
accurate and up-to-date information and/or due to changes in regulations
or University policies. You must always use the form that is currently
posted on the HRPP forms website.
All forms are periodically reviewed to meet changing regulatory or other requirements. For this reason, applications submitted on forms that are outdated by more than 2 months will not be accepted.
To ensure that you are using the most
current form, please always refer to the HRPP website or the COEUS link
each time you need to complete a form for your specific submission. DO
NOT keep template forms on your computer.
Examples of requirements and questions:
1. “Request for Approval of a Social/Behavioral/Educational Study". This form, which is posted on both the social/behavioral and biomedical forms pages, provides a structured application format for those studies that do not include treatment interventions.
2. List the Business Manager and contact information.
3. Funding Source: Indicate ALL of the CURRENT and ACTIVE funding source(s) for this study.
4. Has the funding source changed since this HIC application was last renewed?
5. Did the protocol lapse?If, so complete the following questions (omitted here):
Please note, Effective January 1, 2015, HIC protocols with start date on or after January 1, 2015, will be subject to the new IRB fees at prevailing rates. These rates are NOT locked for the duration of the contract. The change in IRB fees structure is based on a 2014 study of IRB fees charged for industry-sponsored applications across the United States. Please click here to view the new IRB Fees Schedule.
As of June 16, 2014, for NIH JIT Submissions, a protocol /proposal congruency form (100 FR26) completed by the proposal PI must be submitted to the HIC/HSC as part of the protocol application or amendment process. The form is posted on our website under Forms.
Revised IRB Policy 710: REPORTING UNANTICIPATED PROBLEMS INVOLVING RISKS TO SUBJECTS OR OTHERS, INCLUDING ADVERSE EVENTS, TO THE IRB
Effective April 15, 2014, the Yale University Human Research Protection Program (HRPP) revised IRB Policy 710 and related procedures (the policy and procedure for reporting adverse events and unanticipated problems involving risks to subjects or others (UPIRSOs) to the IRB). The changes are as follows:
To aid in understanding reportable events, the new policy includes a decision tree for study personnel to use. In addition, a single reporting form has replaced the previous reporting forms and has been designed to capture required information, to direct the researcher in assessing the event, and to capture the IRB process of event review.
The revised Policy 710 and related documents went in effect as of April 15, 2014. Please review the revised documents carefully. If you have any questions, submit them via email to firstname.lastname@example.org.